Lumen Bioscience

Lumen Bioscience is a clinical-stage biotechnology company dedicated to the research and development of locally and mucosally delivered biologics for the treatment and prevention of highly prevalent diseases. Lumen Bioscience develops and manufactures candidate biologics for highly prevalent diseases, many of which currently lack effective treatments. The company’s unique drug development and manufacturing platform offers the potential to transform the biologics industry by increasing speed, expanding market scale, and achieving much lower costs compared to existing methods. Lumen's clinical development programs include investigational biologics targeting Clostridioides difficile infections, COVID-19, cardiometabolic diseases, inflammatory bowel disease, norovirus, and traveler’s diarrhea.